Status:
RECRUITING
Biomarkers in Parkinsonian Syndromes
Lead Sponsor:
Non-profit organization for scientific research in Parkinson's disease and related disorders
Collaborating Sponsors:
Biomedical Research Foundation, Academy of Athens
Conditions:
Parkinson Disease
Progressive Supranuclear Palsy
Eligibility:
All Genders
Brief Summary
This is a prospective observational study to identify biomarkers in parkinson syndromes. Patients with parkinsonian syndromes at the early stages of disease will be recruited and will be followed up u...
Eligibility Criteria
Inclusion
- IΙnclusion Criteria:
- Written informed consent, including consent to monitoring
- Patients with Parkinsonism and disease duration \< 2 years
- Patients with Parkinsonism and disease duration \> 2 years
- Healthy individuals without any neurological disease
- Exclusion Criteria:
- Drug-induced parkinsonism (eg, neuroleptics, lithium, valproic acid, metoclopramide).
- Metabolic conditions related parkinsonism (eg, Wilson's disease, hypoparathyroidism).
- Structural lesions on brain magnetic resonance imaging (MRI) that explain the symptoms, such as normal pressure hydrocephalus, moderate to severe chronic vascular encephalopathy, cerebral infarction, neoplasm
- Other serious diseases that indicate a life expectancy of \<5 years.
- Active participation in other interventional clinical studies
Exclusion
Key Trial Info
Start Date :
March 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 25 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06501469
Start Date
March 23 2022
End Date
March 25 2030
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HYGEIA Hospital, Parkinson's disease and Movement Disorders Department
Athens, Greece, 15123